↓ Skip to main content

The challenges of access to innovative medicines with limited evidence in the European Union

Overview of attention for article published in Frontiers in Pharmacology, August 2023
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
4 X users

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The challenges of access to innovative medicines with limited evidence in the European Union
Published in
Frontiers in Pharmacology, August 2023
DOI 10.3389/fphar.2023.1215431
Pubmed ID
Authors

Antonio Vallano, Caridad Pontes, Antònia Agustí

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 3 19%
Other 2 13%
Student > Ph. D. Student 2 13%
Student > Doctoral Student 1 6%
Unspecified 1 6%
Other 1 6%
Unknown 6 38%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 19%
Chemistry 2 13%
Biochemistry, Genetics and Molecular Biology 1 6%
Unspecified 1 6%
Medicine and Dentistry 1 6%
Other 1 6%
Unknown 7 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 October 2023.
All research outputs
#16,221,020
of 24,674,524 outputs
Outputs from Frontiers in Pharmacology
#6,065
of 18,726 outputs
Outputs of similar age
#165,732
of 327,087 outputs
Outputs of similar age from Frontiers in Pharmacology
#112
of 691 outputs
Altmetric has tracked 24,674,524 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 18,726 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,087 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 691 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.